Canadian scientists have demonstrated for the first time that a noninvasive brain-monitoring technique could help medical teams predict the future development of premature babies.

Most young patients achieved viral suppression, confirming dolutegravir remains highly effective Researchers urge continued resistance monitoring to protect future treatment options Researchers in ...